Drugs / 25 OH vitamin D
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01323218 | Mar 2011 → Apr 2012 | obstructive sleep apnea syndrome | University Hospital, Clermont-Ferrand | Unknown | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT01585051 Comparator | Jan 2009 → Jun 2010 | type 2 diabetes mellitus | Kantonsspital Baselland Bruderholz | Completed | No outcome recorded |
| Phase 4 | NCT01025128 Comparator | Jan 2010 → Jul 2014 | osteomalacia, secondary hyperparathyroidism, vitamin D deficiency | Clalit Health Services | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 25 OH vitamin D | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01025128 ↗ |
| Route | Oral | “oral supplementation of 25 OH vitamin D” NCT01025128 ↗ |